Removal of target cells by circulating virus-specific cytotoxic t-cells using mhc class i comprising complexes
AssigneeHoffmann-La Roche Inc.
InventorHENDRIK KNOETGEN
Life of this patent
Estimating the term…
Abstract
The invention comprises a complex comprising as first part an antibody derived part that specifically binds to a target antigen, and as second part a virus-derived peptide linked to a MHC class I protein complex.
Claims2
A method for the recombinant production of a complex comprising i) a fusion polypeptide of β2-microglobulin and the extracellular domains α1, α2, and α3 of a class I MHC molecule, ii) a pair of disulfide-linked polypeptide chains derived from an antibody hinge region, and iii) at least one pair of an antibody light chain variable domain and an antibody heavy chain variable domain in a eukaryotic cell, comprising the following steps:
- cultivating a eukaryotic cell comprising one or more nucleic acids encoding the complex, and
- recovering the complex from the cell or the cultivation medium,
- wherein the complex comprises exactly one fusion polypeptide of β2-microglobulin and the extracellular domains α1, α2, and α3 of a class I MHC molecule.
-30. (canceled)
Dependencies are inferred from the claim text.